Prevalence of intratumoral regulatory T cells expressing neuropilin-1 is associated with poorer outcomes in patients with cancer
Christopher A Chuckran(University of Pittsburgh), Dario A.A. Vignali(University of Pittsburgh), James D. Luketich(University of Pittsburgh), John M. Kirkwood(UPMC Hillman Cancer Center), Grant Magnon(University of Pittsburgh), Irina Abécassis(University of Pittsburgh), Lan Coffman(University of Pittsburgh Medical Center), Arjun Pennathur(University of Pittsburgh Medical Center), Sarah E. Taylor(Magee-Womens Research Institute), Tullia C. Bruno(University of Pittsburgh), Brian Orr(Medical University of South Carolina), Umamaheswar Duvvuri(City University of New York), Amer H. Zureikat(UPMC Hillman Cancer Center), Daniel T. Merrick(University of Colorado Anschutz Medical Campus), Jessica Moskovitz(UPMC Hillman Cancer Center), Feng Shan(University of Pittsburgh), John Sembrat(University of Pittsburgh), Ashwin Somasundaram(University of North Carolina at Chapel Hill), Sheryl Kunning(University of Pittsburgh), Robert P. Edwards(Cancer Research UK Technology), Robert E. Schoen(University of Pittsburgh Medical Center), Herbert J. Zeh(Southwestern Medical Center), Francesmary Modugno(University of Pittsburgh), Robert L. Ferris(University of Pittsburgh), Anthony R. Cillo(University of Pittsburgh), Seungwon Kim(UPMC Hillman Cancer Center), Mauricio Rojas(University of Pittsburgh), Ron Buckanovich(University of Pittsburgh), Abigail E. Overacre-Delgoffe(University of Pittsburgh)
Cited by 38
Related Papers
Improved Survival with Vemurafenib in Melanoma with BRAF V600E Mutation
|New England Journal of Medicine|2011|7.7k
Nivolumab for Recurrent Squamous-Cell Carcinoma of the Head and Neck
|New England Journal of Medicine|2016|5.1k
Final Version of 2009 AJCC Melanoma Staging and Classification
|Journal of Clinical Oncology|2009|4.6k
Detection and localization of surgically resectable cancers with a multi-analyte blood test
|Science|2018|2.8k
Melanoma staging: Evidence‐based changes in the American Joint Committee on Cancer eighth edition cancer staging manual
|CA A Cancer Journal for Clinicians|2017|2.3k